Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Huayu Jianpi decoction (YQHYJD) is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Jiangsu Province Hospital of Chinese Medicine. It is primarily utilized as an adjuvant therapeutic for patients with gastric cancer following radical surgery. The decoction is formulated based on TCM principles to tonify Qi, resolve blood stasis, and strengthen the spleen (Jianpi), addressing the systemic imbalances often observed in post-operative cancer patients. Clinical research, including real-world cohort studies, evaluates its efficacy in improving disease-free survival (DFS), reducing tumor markers, enhancing quality of life, and increasing the completion rate of adjuvant chemotherapy by mitigating treatment-related side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Huayu Jianpi decoction.